Indian biosimilar exports, presently valued at $0.8 billion, are expected to grow fivefold to $4.2 billion by 2030 and reach $30-35 billion by 2047 ...
Subscription continues to be charged unless cancelled in Microsoft account. See About Recurring Billing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback